Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katlyn Borgers

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The FEBS Journal|August 17, 2019
A guide to Mycobacterium mutagenesisKatlyn Borgers, Kristof Vandewalle, Nele Festjens, et al.
Antimicrobial Agents and Chemotherapy|July 19, 2021
Exploration of Synergistic Action of Cell Wall-Degrading Enzymes against Mycobacterium tuberculosisLoes van Schie, Katlyn Borgers, Gitte Michielsen, et al.
Vaccine|May 25, 2019
SapM mutation to improve the BCG vaccine: Genomic, transcriptomic and preclinical safety characterizationNele Festjens, Kristof Vandewalle, Erica Houthuys, et al.
Msystems|August 14, 2020
Development of a Counterselectable Transposon To Create Markerless Knockouts from an 18,432-Clone Ordered Mycobacterium bovis Bacillus Calmette-Guérin Mutant ResourceKatlyn Borgers, Kristof Vandewalle, Annelies Van Hecke, et al.
BMC Genomics|July 10, 2019
Reference genome and comparative genome analysis for the WHO reference strain for Mycobacterium bovis BCG Danish, the present tuberculosis vaccineKatlyn Borgers, Jheng-Yang Ou, Po-Xing Zheng, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The FEBS Journal|August 17, 2019
A guide to Mycobacterium mutagenesisKatlyn Borgers, Kristof Vandewalle, Nele Festjens, et al.
Antimicrobial Agents and Chemotherapy|July 19, 2021
Exploration of Synergistic Action of Cell Wall-Degrading Enzymes against Mycobacterium tuberculosisLoes van Schie, Katlyn Borgers, Gitte Michielsen, et al.
Vaccine|May 25, 2019
SapM mutation to improve the BCG vaccine: Genomic, transcriptomic and preclinical safety characterizationNele Festjens, Kristof Vandewalle, Erica Houthuys, et al.
Msystems|August 14, 2020
Development of a Counterselectable Transposon To Create Markerless Knockouts from an 18,432-Clone Ordered Mycobacterium bovis Bacillus Calmette-Guérin Mutant ResourceKatlyn Borgers, Kristof Vandewalle, Annelies Van Hecke, et al.
BMC Genomics|July 10, 2019
Reference genome and comparative genome analysis for the WHO reference strain for Mycobacterium bovis BCG Danish, the present tuberculosis vaccineKatlyn Borgers, Jheng-Yang Ou, Po-Xing Zheng, et al.
Pageof 1